AIG
TRML

American International Group’s Tourmaline Bio TRML Stock Holding History

American International Group’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,113
Closed -$20.9K – 3167
2023
Q1 		$20.9K Buy
1,113
+22
+2% +$363 ﹤0.01% 2887
2022
Q4 		$11.1K Sell
1,091
-4
-0.4% -$64 ﹤0.01% 2983
2022
Q3 		$29K Buy
1,095
+45
+4% +$1.64K ﹤0.01% 2942
2022
Q2 		$47K Sell
1,050
-8
-0.8% -$631 ﹤0.01% 2878
2022
Q1 		$104K Sell
1,058
-75
-7% -$7.02K ﹤0.01% 2582
2021
Q4 		$173K Buy
1,133
+630
+125% +$93.2K ﹤0.01% 2452
2021
Q3 		$68K Buy
503
+4
+0.8% +$548 ﹤0.01% 2928
2021
Q2 		$73 Buy
+499
New +$76.4K ﹤0.01% 2948

Other funds holding TRML

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

American International Group's TRML Position: Q2 2023 in Review

American International Group sold out of Tourmaline Bio (TRML) in Q2 2023, closing a stake of 1,113 shares — an estimated $20.9K sold.

American International Group first reported a position in TRML in Q2 2021 and held it in 8 quarters. The position peaked at $173K in Q4 2021. 58 funds tracked by Wall St. Rank hold TRML as of Q2 2023.

  • American International Group reported no remaining Tourmaline Bio position as of Q2 2023 after selling out during the quarter.
  • American International Group sold 1,113 Tourmaline Bio shares in Q2 2023, an estimated $20.9K.
  • American International Group first reported a position in Tourmaline Bio in Q2 2021 and held it in 8 quarters.
  • American International Group's Tourmaline Bio position peaked at $173K in Q4 2021.
  • 58 funds tracked by Wall St. Rank held Tourmaline Bio as of Q2 2023.

Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.